Trial Profile
Open Label Phase II Study On STI571 (Glivec) [imatinib] Administered As A Daily Oral Treatment In Gliomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 23 Sep 2005 New trial record.